Navigation Links
IRIDEX Reports Growing Revenue and Profits in 2011 First Quarter
Date:5/5/2011

DEX was granted U.S. Patent No. 7,909,816, "Directional Probe Treatment Apparatus." The patent applies to Stepped Angled EndoProbe® laser handpieces, the Company's best-selling class of consumable products and the basis for additional products planned for launch in the coming periods.
  • Results of a new study were published that compares the benefits of MicroPulse photocoagulation technology, similar to that used in the new generation IRIDEX lasers, over the standard-of-care protocol for the treatment of eyes with diabetic macular edema (DME).  The results indicated that treating using MicroPulse mode was as effective as the standard-of-care protocol in treating DME but with the added advantages of causing no localized laser scars and significantly improving visual acuity. DME affects an estimated 2 million people in the U.S.
  • Company approved a stock repurchase program authorizing the Company to purchase in open market or privately negotiated transactions, up to $2,000,000 worth of our Common Stock, from time to time during the next 12 months. 
  • Company launched a formal program of corporate outreach focused on investor and media audiences. Activities during the period included a presentation at the Roth Capital Investor Conference, investor/analyst roadshows, and trade/general media outreach activities.

  • Conference Call IRIDEX management will conduct a conference call later today, Thursday, May 5, 2011 at 5:00 p.m. Eastern Time.  Interested parties may access the live conference call via telephone by dialing (877) 941-1466 (U.S.) or (480) 629-9868 (International) and quoting Conference ID 4435858, or by visiting the Company's website at www.iridex.com. A telephone replay will be available beginning on Thursday, May 5, 2011 through Thursday, May 12, 2011 by dialing (800) 406-7325 (U.S.) or (303) 590-3030 (International) and entering Access Code 4435858. In addition, later to
    '/>"/>

    SOURCE IRIDEX Corporation
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5

    Related medicine technology :

    1. IRIDEX Granted U.S. Patent for Stepped Angled Laser Handpieces Used in Eye Surgery
    2. IRIDEX Announces First Quarter 2011 Conference Call and Release Date
    3. IRIDEX to Present at the Roth OC Growth Stock Conference in Dana Point, CA
    4. IRIDEX Reports Strong Growth and Profits in 2010 Fourth Quarter
    5. IRIDEX to Present at the OneMedForum San Francisco 2011 Conference
    6. IRIDEX Reports Improved Third Quarter 2010 Financial Results
    7. IRIDEX Announces Third Quarter 2010 Conference Call and Release Date
    8. IRIDEX Announces Commercial Availability of New Adjustable & Intuitive EndoProbe® Device for Eye Surgery
    9. IRIDEX Announces Second Quarter 2010 Conference Call and Release Date
    10. IRIDEX Granted U.S. Patent for Adjustable Laser Probe for Eye Surgery
    11. IRIDEX Announces First Commercial Shipment of New IQ 532(TM) Laser Systems
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:3/27/2015)... , March 27, 2015 As of ... of incontinence devices for women. "Shipping ... most gratifying part is the hundreds of letters, ... whose lives have been positively impacted by our ... InControl. InControl recently released Apex, an ...
    (Date:3/27/2015)... --  Hospira, Inc. (NYSE: HSP ), ... leading provider of injectable drugs and infusion technologies, ... biosimilarity of its proposed biosimilar, Epoetin Hospira, with ... approved name of RETACRIT™, compared to the reference ... were presented at the National Kidney Foundation (NKF) ...
    (Date:3/27/2015)... -- Johnson & Johnson (NYSE: JNJ ) will webcast its ... Thursday, April 23, 2015, from the State Theatre in ... other interested parties may access the live audio webcast of ... and clicking on the webcast icon. A ... a few hours after the live meeting concludes.  The webcast ...
    Breaking Medicine Technology:InControl Medical Surpasses 40,000 Shipments Of Incontinence Devices For Women 2Hospira Clinical Data Shows Proposed Biosimilar, Epoetin Hospira, Demonstrates Pharmacokinetic And Pharmacodynamic Equivalence Compared To Amgen's Epogen 2Hospira Clinical Data Shows Proposed Biosimilar, Epoetin Hospira, Demonstrates Pharmacokinetic And Pharmacodynamic Equivalence Compared To Amgen's Epogen 3
    ... LOUIS, March 1, 2011 K-V Pharmaceutical Company (NYSE: KVa/KVb) ... million of senior secured notes due 2015 (the "Notes") in ... The Notes will be offered only to accredited investors pursuant ... amended (the "Securities Act").  The Notes have not been registered ...
    ... Medical Systems Ltd. (Nasdaq: DHRM ) ... the development, assembly, marketing and sale of medical ... announced that management will present at the following ... http://photos.prnewswire.com/prnh/20100422/CNTH001LOGO ) Rodman & Renshaw ...
    Cached Medicine Technology:K-V Pharmaceutical Company Announces $200 Million Private Debt Offering 2K-V Pharmaceutical Company Announces $200 Million Private Debt Offering 3K-V Pharmaceutical Company Announces $200 Million Private Debt Offering 4K-V Pharmaceutical Company Announces $200 Million Private Debt Offering 5K-V Pharmaceutical Company Announces $200 Million Private Debt Offering 6K-V Pharmaceutical Company Announces $200 Million Private Debt Offering 7K-V Pharmaceutical Company Announces $200 Million Private Debt Offering 8Dehaier Medical Announces March Investor Presentations 2
    (Date:3/28/2015)... (PRWEB) March 28, 2015 Early surgery ... with Type V AC joint injuries, according to new ... today at the American Orthopaedic Society for Sports Medicine’s ... to duty faster when surgery was not performed. , ... 7 receiving surgical treatment and 17 receiving non-surgical therapy. ...
    (Date:3/28/2015)... Aureus Medical Group (web: aureusmedical.com), a ... jobs, has announced that it will participate as ... Annual Conference to be held April 10-11, 2015 ... OH. , The OPTA Annual Conference offers ... and services. , Representatives from Aureus Medical’s ...
    (Date:3/28/2015)... ARDX will sponsor the 7th Annual Women’s ... the Chesapeake Conference Center in Chesapeake, Virginia. Each year, ... for women in the Hampton Roads region. The 2015 ... Lives. Women grow stronger through sharing their stories and ... year the WWC™ theme is T-talk where we will share ...
    (Date:3/27/2015)... (PRWEB) March 27, 2015 The ... from dating experts Samantha Sanderson and Jason Rogers has ... buzz of media attention. The commotion surrounding the course's ... prompting him to publish an in-depth review of the ... when the men in their lives suddenly start pulling ...
    (Date:3/27/2015)... York, New York (PRWEB) March 27, 2015 ... ( http://www.lipitorlawsuitcenter.com/ ) that allege the statin medication increases ... diabetes has granted Pfizer Inc.’s Motion to Dismiss four ... According to a Case Management Order issued in the ... 23rd, the Court determined that the dismissals were warranted ...
    Breaking Medicine News(10 mins):Health News:For Type V AC Joint Injuries, Early Surgery May Not Be the Best Approach 2Health News:Healthcare Staffing Leader, Aureus Medical Group, to Exhibit at the Ohio Physical Therapy Association Annual Conference 2Health News:The Monogamy Method - Review Of Samantha Sanderson & Jason Rogers' Relationship Program Released 2Health News:Lipitor Lawsuits Move Forward in Federal Multidistrict Litigation, as Court Rules on Pfizer’s Motion to Dismiss Certain Cases 2Health News:Lipitor Lawsuits Move Forward in Federal Multidistrict Litigation, as Court Rules on Pfizer’s Motion to Dismiss Certain Cases 3
    ... increased 48% over 2006 to $701 million, SAN ... ) today reported financial results for the quarter and,year ... of $222.0,million for the quarter ended December 31, 2007, ... was $76.9 million, or $0.57 per share for,the quarter ...
    ... Launch Vitals.com Which Offers Free Comprehensive Doctor ... Information and Reviews, ... one of the,nation,s top 10 public relations firms, today announced the ... execute a,comprehensive communications program for the free, online doctor evaluation,service., ...
    ... with chronic hepatitis C (HCV) infection should not ... published in Clinical Gastroenterology and Hepatology , ... (AGA) Institute. Researchers found that HCV patients who ... of moderate to severe liver fibrosis, or tissue ...
    ... need of support, THOUSAND OAKS, Calif., Jan. ... experience for women with only a fading,reference to ... Mental,Health Association, in the first three months after ... or exhibit negative,behavior toward their infant. Mothers experiencing ...
    ... The more scientists learn about microRNAs short strands ... the more obvious it becomes how closely they ... at The Wistar Institute and their colleagues have identified ... metastasis. One of the miRNAs may provide an early ...
    ... Psychological interventions for cancer patients do more than just ... research suggests. , A study of 227 breast cancer ... intervention program were rated as having better health by ... started. , One particularly important result was that patients ...
    Cached Medicine News:Health News:Amylin Pharmaceuticals Reports 2007 Financial Results 2Health News:Amylin Pharmaceuticals Reports 2007 Financial Results 3Health News:Amylin Pharmaceuticals Reports 2007 Financial Results 4Health News:Amylin Pharmaceuticals Reports 2007 Financial Results 5Health News:Amylin Pharmaceuticals Reports 2007 Financial Results 6Health News:Amylin Pharmaceuticals Reports 2007 Financial Results 7Health News:MWW Group Selected by First-Ever Online Doctor Evaluation Service Vitals.com 2Health News:Regular marijuana use increases risk of hepatitis C-related liver damage 2Health News:Regular marijuana use increases risk of hepatitis C-related liver damage 3Health News:Blue Cross of California Launches Maternity Depression Program 2Health News:Blue Cross of California Launches Maternity Depression Program 3Health News:2 microRNAs promote spread of tumor cells 2Health News:2 microRNAs promote spread of tumor cells 3Health News:Intervention program boosts health, reduces symptoms in breast cancer patients 2Health News:Intervention program boosts health, reduces symptoms in breast cancer patients 3
    ... Kendall provides hospitals and alternate care ... tracheostomy care trays which offer the ... control. Designed with the guidance of ... trays provide exactly what is required ...
    ... Each KIMBERLY-CLARK BALLARD Component ... T-Pieces, Elbows and Double ... configurations. Customer-oriented presentation to ... sterilized. Also available in ...
    ... permanent flexible tube extension on ... neck flange helps keep connections ... and stoma, enhancing patient mobility ... FlexTend™ tracheostomy tubes improve tube ...
    ... permanent flexible tube extension on ... neck flange helps keep connections ... and stoma, enhancing patient mobility ... FlexTend™ tracheostomy tubes improve tube ...
    Medicine Products: